Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report
Open Access
- 24 February 2016
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 38
Abstract
Non-Shiga toxin-associated hemolytic uremic syndrome is known to be caused by dysregulation of the alternative complement pathway. Infections, drugs, pregnancy, bone marrow transplantation, malignancy, and autoimmune disorders have all been reported to trigger episodes of atypical hemolytic uremic syndrome. To the best of our knowledge, there have been no previous reports of an association between diabetic ketoacidosis and atypical hemolytic uremic syndrome. We describe a case of a 26-year-old Spanish man who presented with diabetic ketoacidosis and was found to have the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. The patient had a normal ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) activity level, and his renal biopsy demonstrated predominant changes of diabetic glomerulosclerosis with an area compatible with thrombotic microangiopathy suggestive of superimposed atypical hemolytic uremic syndrome. Complement sequencing subsequently revealed a potential causative mutation in exon 12 of complement factor B with changes of lysine at amino acid position 533 to an arginine (CFB p.K533R). To the best of our knowledge, this is the first case report of diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult patient.Keywords
This publication has 19 references indexed in Scilit:
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Complement Factor B Mutations in Atypical Hemolytic Uremic Syndrome—Disease-Relevant or Benign?Journal of the American Society of Nephrology, 2014
- A Complement Factor B Mutation in a Large Kindred with Atypical Hemolytic Uremic SyndromeJournal of Clinical Immunology, 2014
- Atypical Hemolytic Uremic SyndromeSeminars in Nephrology, 2013
- Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesionsNephrology Dialysis Transplantation, 2013
- Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor BPediatric Nephrology, 2013
- Genetics and Outcome of Atypical Hemolytic Uremic SyndromeClinical Journal of the American Society of Nephrology, 2013
- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical PhenotypeClinical Journal of the American Society of Nephrology, 2010
- A novel mutation in the Complement Factor B gene (CFB) and atypical hemolytic uremic syndromePediatric Nephrology, 2010
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007